Women's Health

Every pattern of hormonal contraceptive use was associated with subsequent semaglutide initiation, a signal pharmacists and prescribers should watch for.

New survey data reveal information gaps in respiratory syncytial virus immunization decisions.

Viatris' new transdermal patch adds a low-dose estrogen option to the contraceptive landscape.

Researchers explore prenatal alcohol use among expectant mothers in the US spanning 2011 to 2024.

A new survey shows widespread uncertainty about which vaccines the CDC recommends during pregnancy, underscoring the counseling role pharmacists play.

Pharmacists and other clinicians counseling postpartum patients may find more success with meal-timing strategies that require minimal disruption to routines.

In this episode, Natalie DiPietro Mager, PharmD, PhD, talks with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, about how pharmacists can address cannabis use in women during adolescence, reproductive years, and older adulthood.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Alyssa Perry, PharmD to discuss the pharmacist’s role in ensuring inclusive and respectful care for members of the LGBTQ+ community.

This schedule arrives at a time of unprecedented friction between leading medical societies and federal health agencies.

Pharmacists help women choose safer hormone replacement therapy or nonhormonal relief options.

Learn practical do’s and don’ts for male pharmacists to deliver private, inclusive, evidence-based birth control counseling patients trust.

In a health care landscape of silos and fragmentation, especially in the menopause space, pharmacists have increasingly provided their efforts to better care coordination for their communities.

In part 2, Miller further breaks down the fragmentation of menopause care within today’s health care system and how pharmacists are uniquely positioned to fill in long-standing care gaps.

American College of Cardiology's new postpartum cardiovascular disease pathway urges early follow-up and tighter blood pressure goals.

New FDA guidance sharpens postmarket pregnancy drug safety data, improving labels and empowering pharmacists to report adverse events.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Sarah Chew, MPH, to discuss the pharmacist’s role in advancing women’s health research.

With continued pressure for federal action regarding the abortion drug mifepristone, SCOTUS blocked a previous decision that would limit the pill’s access.

In a recent research letter, investigators establish how removal of in-person dispensing requirements impact mifepristone pharmacy access.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Kami Dixon, MD, MA, to discuss the racial disparities across women’s health in the US.

With persistent challenges in the arena of US maternal health care, researchers assess pharmacists’ knowledge, confidence, and perceived barriers in filling maternal health gaps.

As debates heat up between anti-abortion and pro-life advocates, the federal government places a hold on any action toward mifepristone’s approval.

New evidence links poor sleep and diabetes risk to widespread prenatal anxiety, urging pharmacists to support metabolic control and mental health.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

Investigators used a large cohort of patients from Taiwan between 2004 and 2015 to determine the potential link between Tylenol use and childhood neurodevelopment.

US pharmacists can prescribe contraception through streamlined pharmacy care, expanding access; supporting maternity deserts; and improving women’s health.